141.      Wood RFM, Thompson JF, Ting A, Benjamin IS, Allen NH, Morris PJ. A       randomised controled trial of short-term cyclosporin therapy in renal transplantation (Trial II). Transplant Proc 1985;17:1164-5.

140.      Vincent PC, Joyce RM, Croaker G, Young GA, Milton GW, McCarthy WH. Semi-solid cultures of primary melanomas and their correlation with histopathological features. Pathology 1985;17:360-4.

139.      Urist MM, Balch CM, Soong S, Shaw HM, Milton GW, Maddox WA. The influence of surgical margins and prognostic factors predicting the risk of local recurrence in 3445 patients with primary cutaneous melanoma. Cancer 1985;55:1398-402.

138.      Tiller DJ, Hall BM, Horvarth JS, Duggin GG, Thompson JF, Sheil AG. Gout and hyperuricaemia in patients on cyclosporin and diuretics. Lancet 1985;1:453.

137.      Thompson JF, Carter NP, Bolton EM, McWhinnie DL, Wood RFM, Morris PJ. The composition of the lymphocyte infiltrate in rejecting human renal allografts is not reflected by lymphocyte subpopulations in the peripheral blood. Transplant Proc 1985;17:556-7.

136.      Thompson JF, Allen R, Morris PJ, Wood R. Skin cancer in renal transplant patients treated with cyclosporin. Lancet 1985;1:158-9.

135.      Shaw HM, Beattie CW, McCarthy WH, Milton GW. Late relapse from cutaneous stage I malignant melanoma. Arch Surg 1985;120:1155-9.

134.      Shaw HM, Balch CM, Soong SJ, Milton GW, McCarthy WH. Prognostic histopathological factors in malignant melanoma. Pathology 1985;17:271-4.

133.     Milton GW, Shaw HM, McCarthy WH. Resection margins for melanoma. Aust N Z J Surg 1985;55:225-6.

132.     Milton GW, Shaw HM, McCarthy WH. Subungual malignant melanoma: a disease entity separate from other forms of cutaneous melanoma. Australas J Dermatol 1985;26:61-4.

131.     McWhinnie DL, Thompson JF, Taylor HM, Chapman JR, Bolton EM, Wood RFM, Morris PJ. Leucocyte infiltration patterns in renal allografts assessed by immunoperoxidase staining of 245 sequential biopsies. Transplant Proc 1985;17:560-1.

130.     McGovern VJ, Shaw HM, Milton GW. Histogenesis of malignant melanoma with an adjacent component of the superficial spreading type. Pathology 1985;17:251-4.

129.     McCarthy WH, Shaw HM, Milton GW. Efficacy of elective lymph node dissection in 2,347 patients with clinical stage I malignant melanoma. Surg Gynecol Obstet 1985;161:575-80.

128.      Hersey P, Murray E, Grace J, McCarthy WH. Current research on immunopathology of melanoma: analysis of lymphocyte populations in relation to antigen expression and histological features of melanoma. Pathology 1985;17:385-91.

127.      Hersey P, Hasic E, MacDonald M, Edwards A, Spurling A, Coates AS, Milton GW, McCarthy WH. Effects of recombinant leukocyte interferon (rIFN-alpha A) on tumour growth and immune responses in patients with metastatic melanoma. Br J Cancer 1985;51:815-26.

126.      Hall BM, Tiller DJ, Horvarth JS, Duggin GG, Johnson JR, Roy LP, Hurley B, Harris JP, Rogers JR, Stephen MS, Boulas J, Thompson JF, May J, Sheil AGR. Treatment of renal transplantation rejection.  Cyclosporin A versus conventional treatment with azathioprine, prednisone and antithymocyte immunoglobulin in primary cadaver renal transplants. Med J Aust 1985;142:179-85.

125.     Gray DWR, Thompson JF, Millard PR, Wood RFM, Morris PJ. Venous thrombosis following segmental pancreatic transplantation using latex duct occlusion. Transplant Proc 1985;17:2026-8.

124.      d'Ardenne AJ, Dunnill MS, Wood RFM, Thompson JF, Morris PJ. Cyclosporine treatment does not cause specific histologic changes in human renal allografts. Transplant Proc 1985;17:1164-5.

123.      Chapman JR, Thompson JF, Wood RFM, Morris PJ. The problems associated with conversion to cyclosporine immunosuppression in long-term renal allograft recipients. Transplant Proc 1985;17:1176-80.

122.     Wood RFM, Thompson JF, Carter NP. Changes in lymphocyte subpopulations in blood and kidney after renal transplantations. In: Morris PJ, Tilney NL, eds. Progress in Transplantation. Edinburgh, London, Melbourne and New York: Churchill Livingstone; 1984:149-85.

121.     Wood RFM, Thompson JF, Allen NH, Ting A, Morris PJ. The consequences of conversion from Cyclosporine to Azathioprine and prednisolone in renal allograft recipients. In: Kahan BD, ed. Cyclosporine - Biological Activity and Clinical Applications. Orlando & London: Grune & Stratton; 1984:646-52.

120.      Urist MM, Balch CM, Soong SJ, Milton GW, Shaw HM, McGovern VJ, Murad TM, McCarthy WH, Maddox WA. Head and neck melanoma in 534 clinical Stage I patients. A prognostic factors analysis and results of surgical treatment. Ann Surg 1984;200:769-75.

119.      Thompson JF, Walker CJ. Management of pancreatic carcinoma. Intenal Medicine Digest 1984;6:29-30.

118.      Thompson JF, Fletcher EW, Wood RF, Chalmers DH, Taylor HM, Benjamin IS, Morris PJ. Control of hypertension after renal transplantation by embolisation of host kidneys. Lancet 1984;2:424-7.

117.      Thompson JF, Chapman JR. Dialysis and transplantation. In: Morris PJ, ed. Kidney Transplantation - Principles and Practice. 2 ed. London, Orlando & New York: Grune & Stratton; 1984:33-58.

116.      Rossleigh MA, McCarthy WH, Morris JG. Coincidental diagnosis of clinically undetectable primary breast carcinoma with a gallium-67 study performed for assessment of spread of malignant melanoma. Aust N Z J Surg 1984;54:391-2.

115.     Rossleigh MA, McCarthy WH, Milton GW, McLaughlin AF, Uren RF, Bautovich GJ, Singer I, Morris JG. The role of gallium-67 studies in the management of malignant melanoma. Med J Aust 1984;140:401-3.

114.     Morris PJ, Thompson JF, Ting A, Wood RF. Is pregraft blood transfusion beneficial in cyclosporin-treated renal transplant recipients? Lancet 1984;1:98.

113.     Malden LT, Coates AS, Milton GW, McCarthy WH, Levi JA, Woods RL, Byrne MJ, Reynolds PM, Fox RM, Hedley DW, et al. Mitolactol chemotherapy for malignant melanoma: a phase II study. Cancer Treat Rep 1984;68:1045-6.

112.     Kurtz JB, Thompson JF, Ting A, Pinto A, Morris PJ. The problem of cytomegalovirus infection in renal allograft recipients. The Quarterly Journal of Medicine 1984;53:341-9.

111.     Fletcher EW, Thompson JF, Chalmers DH, Taylor HM, Wood RF, Morris PJ. Embolisation of host kidneys for the control of hypertension after renal transplantation: radiological aspects. Br J Radiol 1984;57:279-84.

110.      Caterson RJ, Furber J, Murray J, McCarthy W, Mahony JF, Sheil AG. Carcinoma of the vulva in two young renal allograft recipients. Transplant Proc 1984;16:559-61.

109.      Carter NP, Bewick ALT, Bolton EM, Thompson JF, Wood RFM, Morris PJ. Flow cytometric analysis of fine needle aspiration biopsies of human renal allografts. In: Kreis H, Droz D, eds. Renal Transplant Cytology. Milan: Wichtig Editore; 1984:45-55.

108.      Bradlow A, Thompson JF, Morris PJ, Watson NA. Multiple spontaneous ruptures of tendons in renal transplant recipient. Br Med J (Clin Res Ed) 1984;288:364-5.

107.      Bolton EM, Thompson JF, Morris PJ. Lymphocyte subpopulations in fine needle aspiration biopsies determined by immunoperoxidase staining. In: Kreis H, Droz D, eds. Renal Transplant Cytology. Milan: Wichtig Editore; 1984.

106.      Beral V, Evans S, Shaw H, Milton G. Oral contraceptive use and malignant melanoma in Australia. Br J Cancer 1984;50:681-5.